Plain-English translation of NCT05880667 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing adaptive stereotactic body radiation therapy (SBRT)—a type of highly focused radiation treatment—to see what dose works best and is safest for people with cancer that has spread to the abdomen or pelvis. Researchers want to find the highest dose that patients can tolerate without serious side effects, so they can recommend the best dose for future patients.
Cancer that spreads to the abdomen and pelvis is difficult to treat because radiation can damage nearby healthy organs. This trial exists to find out if newer, more precise radiation techniques can deliver higher doses safely, which might improve how well the treatment works.
You likely qualify if…
You likely don't qualify if…
You would come to the hospital for a simulation appointment and then receive radiation therapy over 3 to 4 weeks. The radiation is delivered in focused beams aimed directly at your tumors, with planning scans to make sure the treatment is precise. Your doctors will monitor you closely to watch for any side effects and decide whether to increase, keep the same, or decrease the radiation dose based on how you respond.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States